English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

This study was undertaken to determine Free to Total PSA ratio to differentiate between Benign Prostate Hyperplasia (BPH) and Prostate Cancer (PCa) and to improve the accuracy of the PSA test and the specificity of PCa detection particularly when PSA levels fall between 4-10ng/ml levels. The study group consisted of a total of 124 subjects. Free PSA and Total PSA were determined using assay, which is based on Chemiluminescent Microparticle Immunoassay (CMIA) technology. The Statistical test used were Students’ t test for difference of Mean and Pearson Correlation test, using SPSS and MS Excel Statistical packages. Free/Total PSA ratios in the prostate cancer group were significantly lower than those in the BPH group. A cut-off of F/T PSA ratio% at 18% improves diagnostic sensitivity and specificity for prostate cancer.

Role Of Free / Total Psa Ratio To Differentiate Bph And Prostate Cancer